Even if several studies have reported the beneficial and preventive role of therapeutics ACE2 in COVID-19 [39], clinical data suggest that comorbid and older patients with low membrane ACE2 and high sACE2 faced greater disease severity and fatality [40]. This evidence concerns the gene ACE2 and COVID-19.